Rosefinch Pharmaceutique Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 10.86 Cr
as on 17-11-2024
- Company Age 8 Year, 13 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 35.85 Cr
as on 17-11-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth 28.60%
(FY 2023)
- Total Assets 88.53%
(FY 2023)
About Rosefinch Pharmaceutique
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 10.86 Cr.
The company currently has active open charges totaling ₹35.85 Cr.
The Key Managerial Personnel (KMP) at Rosefinch Pharmaceutique Private Limited India is Mahesh Purohit as COMPANY SECRETARY. Jaydeep Raigagla, Chiragbhai Paleja, Aditya Bhatt, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24299GJ2016PTC094820
- Company No.
094820
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Amreli, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rosefinch Pharmaceutique?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Purohit  | Company Secretary | 16-May-2023 | Current |
| Milankumar Trivedi | Managing Director | 22-Dec-2016 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jaydeep Raigagla | Director | 07-Jun-2024 | Current |
| Chiragbhai Paleja | Director | 22-Dec-2016 | Current |
| Aditya Bhatt | Director | 26-Dec-2017 | Current |
| Vijaybhai Nagecha | Director | 01-Sep-2021 | Current |
| Chetan Hansalia | Director | 01-Sep-2021 | Current |
| Abhishek Rabara | Director | 28-Aug-2022 | Current |
Financial Performance of Rosefinch Pharmaceutique.
Rosefinch Pharmaceutique Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 28.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rosefinch Pharmaceutique?
In 2023, Rosefinch Pharmaceutique had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rosefinch Lifesciences Private LimitedActive 12 years 6 monthsChiragbhai Paleja, Aditya Bhatt and 1 more are mutual person
- Rosefinch Advisors Private LimitedActive 9 years 11 months
Chiragbhai Paleja, Aditya Bhatt and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Dec 2021 | ₹2.03 M | Open |
State Bank Of India Creation Date: 22 Nov 2021 | ₹35.65 Cr | Open |
How Many Employees Work at Rosefinch Pharmaceutique?
Unlock and access historical data on people associated with Rosefinch Pharmaceutique, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rosefinch Pharmaceutique, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rosefinch Pharmaceutique's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
